Free Exubera and NICE Case Study Solution | Assignment Help

MBA Staff Writer
Written by Gary F. Smith
Publish Date: 2024-12-03

Harvard Case - Exubera and NICE

"Exubera and NICE" Harvard business case study is written by Stefanos Zenios, Robert Chess, Lyn Denend. It deals with the challenges in the field of Operations Management. The case study is 14 page(s) long and it was first published on : Jan 2, 2008

At Fern Fort University, we recommend that Exubera re-evaluate its operations strategy and supply chain management to address the challenges posed by the NICE decision. This involves a comprehensive overhaul of its manufacturing processes, product development, and logistics to ensure the long-term viability of the product. This recommendation is based on a detailed analysis of the case, considering factors such as innovation, technology and analytics, international business, and environmental sustainability.

2. Background

Exubera, a novel inhaled insulin product developed by Pfizer, faced a critical decision when the National Institute for Health and Clinical Excellence (NICE) in the UK declined to recommend its use within the National Health Service (NHS). This decision was based on the high cost of Exubera compared to traditional insulin therapies, despite its potential benefits for patients. The case study focuses on the challenges faced by Exubera in the wake of this decision, highlighting the complexities of product development, market entry, and pricing strategies in the pharmaceutical industry.

The main protagonists of the case study are:

  • Pfizer: The pharmaceutical giant responsible for developing and marketing Exubera.
  • NICE: The independent body responsible for evaluating the cost-effectiveness of healthcare treatments in the UK.
  • Patients: The target audience for Exubera, who stand to benefit from its potential advantages.

3. Analysis of the Case Study

This case study presents a complex scenario where innovation and product development are challenged by the economic realities of the healthcare market. The following frameworks can be used to analyze the case:

Strategic Framework:

  • Porter's Five Forces: Analyzing the competitive landscape reveals intense rivalry among pharmaceutical companies, a high threat of substitutes (traditional insulin therapies), and significant bargaining power of buyers (NHS).
  • Value Chain Analysis: Exubera's value chain is complex, involving R&D, manufacturing, distribution, and marketing. The NICE decision highlights the importance of cost optimization along the entire value chain.

Financial Framework:

  • Cost-Benefit Analysis: NICE's decision was based on the cost-effectiveness of Exubera compared to existing treatments. Pfizer needs to demonstrate a strong return on investment to justify the high price point.
  • Net Present Value (NPV): Evaluating the long-term profitability of Exubera requires considering factors such as market penetration, pricing strategies, and potential future cost reductions.

Operational Framework:

  • Supply Chain Management: Exubera's complex production processes and logistics require a robust and efficient supply chain to ensure consistent product availability.
  • Lean Manufacturing: Implementing lean principles can help optimize inventory management, reduce waste, and improve overall efficiency.

4. Recommendations

To address the challenges posed by the NICE decision, Exubera needs to adopt a comprehensive strategy that focuses on:

  1. Cost Reduction:
    • Process Improvement: Implement Six Sigma and Lean Manufacturing principles to identify and eliminate inefficiencies within the manufacturing process.
    • Supply Chain Optimization: Leverage technology and analytics to improve demand forecasting, optimize inventory control, and streamline logistics.
    • Outsourcing: Consider outsourcing certain manufacturing or distribution activities to reduce costs and improve efficiency.
  2. Value Proposition Enhancement:
    • Product Development: Focus on innovation to improve the efficacy and convenience of Exubera, potentially leading to a stronger value proposition for patients.
    • Marketing: Develop a targeted marketing campaign that highlights the unique benefits of Exubera, emphasizing its potential to improve patient outcomes.
  3. Market Expansion:
    • International Business: Explore opportunities in other markets where the regulatory environment and pricing structures are more favorable.
    • New Business Models: Consider alternative business models such as pay-for-performance or value-based pricing to address the cost-effectiveness concerns.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  1. Core Competencies and Consistency with Mission: Pfizer's core competency lies in drug development and innovation. The recommendations align with this by focusing on process improvement and product development to enhance the value proposition of Exubera.
  2. External Customers and Internal Clients: The recommendations prioritize the needs of both patients and healthcare providers, aiming to improve patient outcomes and reduce costs for the NHS.
  3. Competitors: The recommendations aim to position Exubera as a competitive alternative to traditional insulin therapies by addressing cost-effectiveness concerns and enhancing its value proposition.
  4. Attractiveness ' Quantitative Measures: The recommendations are expected to improve profitability by reducing costs, increasing market share, and achieving a stronger return on investment.

6. Conclusion

Exubera faces significant challenges in the wake of the NICE decision. However, by implementing a comprehensive strategy that focuses on cost reduction, value proposition enhancement, and market expansion, Exubera can overcome these challenges and establish itself as a viable treatment option for patients with diabetes. This requires a commitment to continuous improvement, innovation, and a strategic approach to supply chain management.

7. Discussion

Other alternatives not selected include:

  • Abandoning Exubera: This option would be a significant loss for Pfizer, given the investment already made in the product. It also fails to address the needs of patients who could benefit from Exubera.
  • Maintaining the status quo: This would likely lead to continued financial losses and a decline in market share.

The key assumptions of our recommendations are:

  • Pfizer is committed to the long-term success of Exubera.
  • The market for inhaled insulin is expected to grow in the future.
  • Pfizer can successfully implement the recommended changes to its operations and supply chain.

8. Next Steps

To implement the recommendations, Pfizer should:

  • Form a cross-functional team to oversee the implementation of the strategy.
  • Develop a detailed implementation plan with clear timelines and milestones.
  • Conduct ongoing monitoring and evaluation to track progress and make adjustments as needed.

By taking these steps, Pfizer can ensure the long-term success of Exubera and position it as a leading treatment option for patients with diabetes.

Hire an expert to write custom solution for HBR Operations Management case study - Exubera and NICE

Case Description

Historically, the biggest obstacle that healthcare innovators, such as pharmaceutical and medical device manufacturers, needed to overcome on their way to market was securing approval by the U.S. Food & Drug Administration (FDA) or other international regulatory authorities. However, in the last decade, a new (sometimes even more challenging) hurdle had to be cleared: insurance coverage and reimbursement. Payers--either public payers, such as Medicare in the U.S. and the National Health Services (NHS) in the U.K., or private commercial payers, such as Blue Cross/Blue Shield and UnitedHealth Grou--could deny coverage for a technology that had received regulatory approval if they determined that the supporting evidence did not adequately demonstrate that the technology was superior to existing treatment alternatives that were already being reimbursed. This had the potential to create a potentially adversarial relationship between payers and innovators in cases where they had conflicting interpretations of the evidence regarding the cost, benefits, and risks of new technologies. The challenges to innovators in managing this conflict are illustrated in this case study by an example: the 2006 decision by the U.K.'s NHS to deny coverage for Exubera, a new form of inhaled insulin.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Exubera and NICE

Hire an expert to write custom solution for HBR Operations Management case study - Exubera and NICE

Exubera and NICE FAQ

What are the qualifications of the writers handling the "Exubera and NICE" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Exubera and NICE ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Exubera and NICE case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Exubera and NICE. Where can I get it?

You can find the case study solution of the HBR case study "Exubera and NICE" at Fern Fort University.

Can I Buy Case Study Solution for Exubera and NICE & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Exubera and NICE" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Exubera and NICE solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Exubera and NICE

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Exubera and NICE" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Exubera and NICE"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Exubera and NICE to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Exubera and NICE ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Exubera and NICE case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Exubera and NICE" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Operations Management case study - Exubera and NICE

Top Sellers

Most Read

Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.